YHB Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
GA
VF
WCM
AIP
YHB Investment Advisors's REGN Position: Q2 2026 in Review
YHB Investment Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 568 shares worth $354K. The position accounts for 0.02% of the portfolio, ranked #251.
YHB Investment Advisors first reported a position in REGN in Q3 2019 and has held it in 28 quarters since. The position peaked at $607K in Q3 2024. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- YHB Investment Advisors held 568 shares of Regeneron Pharmaceuticals worth $354K as of Q2 2026.
- YHB Investment Advisors left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
- Regeneron Pharmaceuticals made up 0.02% of YHB Investment Advisors's portfolio in Q2 2026, its #251 holding.
- YHB Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
- YHB Investment Advisors's Regeneron Pharmaceuticals position peaked at $607K in Q3 2024.
- 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.